查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区下一代 IVD 市场：分析与预测（2023-2033）
市场调查报告书
商品编码
1439023

亚太地区下一代 IVD 市场：分析与预测（2023-2033）

Asia-Pacific Next-Generation IVD Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 99 Pages | 商品交期: 1-5个工作天内

价格
主要市场统计数据
预测期 2023-2033
2023年评估价值 214.3亿美元
2033年预测 423.5亿美元
复合年增长率 7.05%

2023年亚太地区新一代IVD（体外诊断）市值为214.3亿美元。

预计2033年市场规模将达423.5亿美元，2023年至2033年复合年增长率为7.05%。诊断创新技术的出现有可能推动下一代 IVD（体外诊断）市场的成长。分子诊断、基因组学和次世代定序(NGS) 预计将在推动这一增长方面发挥关键作用，为加强疾病检测并最终改变患者治疗结果提供新的机会。

亚太地区正在见证下一代 IVD（体外诊断）市场的重大进展和成长。有几个重要因素促成了这种扩张。首先，慢性病和感染疾病的增加需要更准确、更有效率的诊断解决方案。其次，中国、印度和日本等国家的快速都市化和不断上涨的医疗成本正在推动先进诊断技术的采用。第三，医疗保健提供者和患者对个人化医疗和早期疾病检测的好处的认识不断提高，推动了对创新 IVD 解决方案的需求。此外，旨在改善医疗基础设施和促进研发活动的政府支持措施也促进了亚太市场的成长。

该报告研究了亚太地区下一代 IVD 市场，并提供了市场概述，包括按类型、最终用户、国家/地区分類的趋势以及参与市场的公司概况。

目录

执行摘要

第一章 市场

  • 产品定义
  • 市场范围
  • 调查方法

第二章 市场概况

  • 介绍
  • COVID-19 对下一代 IVD 市场的影响

第三章产业分析

  • 法律要求
    • 亚太地区的法律要求与框架

第 4 章 下一代 IVD 市场，按地区，百万美元，2022-2033

  • 概述
  • 亚太地区
    • 市场动态
    • 市场规模及预测

第五章 公司简介

  • 活跃于下一代 IVD 市场生态系统的公司
  • Sysmex Corporation
Product Code: BHP1912SS

The Asia-Pacific Next-Generation IVD Market Expected to Reach $42.35 Billion by 2033

Introduction to Asia-Pacific Next-Generation IVD (In vitro diagnostics) Market

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$21.43 Billion
2033 Forecast$42.35 Billion
CAGR7.05%

The Asia-Pacific next-generation IVD market was valued at $21.43 billion in 2023 and is expected to reach $42.35 billion by 2033, growing at a CAGR of 7.05% between 2023 and 2033. The emergence of innovative technologies in diagnostics holds promise for revitalizing the growth of the next-generation In Vitro Diagnostics (IVD) market. Molecular diagnostics, genomics, and Next-Generation Sequencing (NGS) are anticipated to play pivotal roles in driving this growth, offering fresh opportunities for enhanced disease detection and ultimately transforming patient outcomes.

Market Introduction

The Asia-Pacific (APAC) region is witnessing significant advancements and growth in the Next-Generation In Vitro Diagnostics (IVD) market. This expansion is fueled by several key factors. Firstly, the increasing prevalence of chronic diseases and infectious ailments necessitates more accurate and efficient diagnostic solutions. Secondly, rapid urbanization and rising healthcare expenditures in countries like China, India, and Japan are driving the adoption of advanced diagnostic technologies. Thirdly, growing awareness among healthcare providers and patients regarding the benefits of personalized medicine and early disease detection is spurring demand for innovative IVD solutions. Additionally, supportive government initiatives aimed at improving healthcare infrastructure and promoting research and development activities further contribute to market growth in the APAC region.

Market Segmentation:

Segmentation 1: by Type

  • Core Laboratory Diagnostics
  • POC Testing
  • Molecular Diagnostics

Segmentation 2: by End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Academic and Research Institutions
  • Other End Users

Segmentation 3: by Country

  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The next-generation IVD market has been extensively segmented on the basis of various categories, such as type, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The next-generation IVD market has numerous startups paving their way into manufacturing kits, panels, assays, and instruments and entering the market. Key players in the next-generation IVD market analyzed and profiled in the study involve established players that offer various kinds of disease-specific panels and multiplex instruments.

Table of Contents

Executive Summary

1 Markets

  • 1.1 Product Definition
    • 1.1.1 Inclusion and Exclusion Criteria
  • 1.2 Market Scope
    • 1.2.1 Key Questions Answered in the Report
  • 1.3 Research Methodology
    • 1.3.1 Next-Generation IVD Market: Research Methodology
    • 1.3.2 Data Sources
      • 1.3.2.1 Primary Data Sources
      • 1.3.2.2 Secondary Data Sources
    • 1.3.3 Market Estimation Model
    • 1.3.4 Criteria for Company Profiling

2 Market Overview

  • 2.1 Introduction
    • 2.1.1 Next-Generation IVD Market Outlook
      • 2.1.1.1 POC-IVD
      • 2.1.1.2 Diagnostic Expenditures
      • 2.1.1.3 Pricing Patterns of Next-Generation IVD
    • 2.1.2 Market Size and Growth Potential
      • 2.1.2.1 Short-Term Impact (2020-2025)
      • 2.1.2.2 Long-Term Impact (2026-2033)
    • 2.1.3 Product Benchmarking by Next- Generation In-vitro Diagnostics Market, (by Type)
  • 2.2 COVID-19 Impact on the Next-Generation IVD Market
    • 2.2.1 Impact on Operations
    • 2.2.2 COVID-19 Impact: Current Scenario of the Market
    • 2.2.3 Pre-COVID Assessment
    • 2.2.4 Post-COVID-19 Market Assessment

3 Industry Analysis

  • 3.1 Legal Requirements
    • 3.1.1 Legal Requirements and Framework in Asia-Pacific

4 Next-Generation IVD Market, by Region, $Million, 2022-2033

  • 4.1 Overview
  • 4.2 Asia-Pacific
    • 4.2.1 Market Dynamics
    • 4.2.2 Market Size and Forecast
      • 4.2.2.1 Asia-Pacific Next-Generation IVD Market (by End User)
      • 4.2.2.2 Asia-Pacific Next-Generation IVD Market (by Type)
        • 4.2.2.2.1 Asia-Pacific Next-Generation Core Laboratory IVD Market, (by Type)
      • 4.2.2.3 Asia-Pacific Next-Generation IVD Market (by Country)
        • 4.2.2.3.1 China
          • 4.2.2.3.1.1 Market Size and Forecast
          • 4.2.2.3.1.1.1 China Next-Generation IVD Market (by End User)
          • 4.2.2.3.1.1.2 China Next-Generation IVD Market (by Type)
        • 4.2.2.3.2 Japan
          • 4.2.2.3.2.1 Market Size and Forecast
          • 4.2.2.3.2.1.1 Japan Next-Generation IVD Market (by End User)
          • 4.2.2.3.2.1.2 Japan Next-Generation IVD Market (by Type)
        • 4.2.2.3.3 India
          • 4.2.2.3.3.1 Market Size and Forecast
          • 4.2.2.3.3.1.1 India Next-Generation IVD Market (by End User)
          • 4.2.2.3.3.1.2 India Next-Generation IVD Market (by Type)
        • 4.2.2.3.4 Australia
          • 4.2.2.3.4.1 Market Size and Forecast
          • 4.2.2.3.4.1.1 Australia Next-Generation IVD Market (by End User)
          • 4.2.2.3.4.1.2 Australia Next-Generation IVD Market (by Type)
        • 4.2.2.3.5 South Korea
          • 4.2.2.3.5.1 Market Size and Forecast
          • 4.2.2.3.5.1.1 South Korea Next-Generation IVD Market (by End User)
          • 4.2.2.3.5.1.2 South Korea Next-Generation IVD Market (by Type)
        • 4.2.2.3.6 Rest-of-Asia-Pacific
          • 4.2.2.3.6.1 Market Size and Forecast
          • 4.2.2.3.6.1.1 Rest-of-Asia-Pacific Next-Generation IVD Market (by End User)
          • 4.2.2.3.6.1.2 Rest-of-Asia-Pacific Next-Generation IVD Market (by Type)

5 Company Profiles

  • 5.1 Overview
  • 5.2 Next-Generation IVD Market Ecosystem Active Players
  • 5.3 Sysmex Corporation
    • 5.3.1 Company Overview
    • 5.3.2 Role of Sysmex Corporation in the Next-Generation IVD Market
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
      • 5.3.4.1 Business Strategies
    • 5.3.5 Analyst Perspective

List of Figures

  • Figure 1: Facts about Next-Generation IVD Market
  • Figure 2: Equipment's used for Next-Generation In-Vitro Diagnostics
  • Figure 3: Asia-Pacific Next-Generation IVD Market, $Billion, 2022 and 2033
  • Figure 4: Trend Analysis of Next-Generation In-vitro Diagnostics Ecosystem
  • Figure 5: Common Chronic Conditions for Population Above 65 years
  • Figure 6: Key Challenges in the Asia-Pacific Next-Generation IVD Market based on Primary Respondents
  • Figure 7: New In-Vitro Diagnostics Regulations (IVDR) and Medical Device Regulation (MDR)
  • Figure 8: Major Highlights Witnessed in the Next-Generation IVD Market During COVID-19 Impact
  • Figure 9: Role of POC Diagnostics in Next-Generation IVD Market During Pandemic
  • Figure 10: Leading and Emerging Companies in the Next-Generation IVD Ecosystem
  • Figure 11: Leading Companies in the Next-Generation IVD Ecosystem and Their Market Share (%)
  • Figure 12: Key Developments Undertaken by Companies in the Next-Generation IVD Market, July 2019-June 2023
  • Figure 13: Product Benchmarking of Next-Generation In-Vitro Diagnostics Ecosystem (by Test)
  • Figure 14: Asia-Pacific Next-Generation IVD Market (by Type), Share (%), 2022 and 2033
  • Figure 15: Asia-Pacific Next-Generation IVD Market (by End User), Share (%), 2022 and 2033
  • Figure 16: Next-Generation IVD Market: Research Methodology
  • Figure 17: Primary Research Methodology
  • Figure 18: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 19: Top-Down Approach (Segment-Wise Analysis)
  • Figure 20: Asia-Pacific Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 21: Product Benchmarking of Next-Generation In-vitro Diagnostics Market (by Type)
  • Figure 22: In-Vitro Diagnostic Trends during the COVID-19 Pandemic
  • Figure 23: Timeline of IVDR 2017/746
  • Figure 24: Next-Generation IVD Market (by Region), Share (%), 2022
  • Figure 25: Next-Generation IVD Market (by Region), $Billion, 2022-2033
  • Figure 26: Asia-Pacific Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 27: Asia-Pacific Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 28: Asia-Pacific Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 29: Asia-Pacific Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 30: Asia-Pacific Next-Generation IVD Market (by Country), $Billion, 2022-2033
  • Figure 31: China Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 32: China Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 33: China Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 34: China Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 35: Japan Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 36: Japan Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 37: Japan Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 38: Japan Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 39: India Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 40: India Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 41: India Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 42: India Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 43: Australia Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 44: Australia Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 45: Australia Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 46 Australia Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 47: South Korea Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 48: South Korea Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 49: South Korea Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 50: South Korea Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 51: Rest-of-Asia-Pacific Next-Generation IVD Market, $Billion, 2022-2033
  • Figure 52: Rest-of-Asia-Pacific Next-Generation IVD Market (by End User), $Billion, 2022-2033
  • Figure 53: Rest-of-Asia-Pacific Next-Generation IVD Market (by Type), $Billion, 2022-2033
  • Figure 54: Rest-of-Asia-Pacific Next-Generation Core Laboratory IVD Market (by Type), $Billion, 2022-2033
  • Figure 55: Total Number of Companies Profiled
  • Figure 56: Sysmex Corporation: Product Portfolio
  • Figure 57: Sysmex Corporation: Overall Financials, $Million, 2020-2022
  • Figure 58: Sysmex Corporation: Revenue (by Segment), $Million, 2020-2022
  • Figure 59: Sysmex Corporation: Revenue (by Region), $Million, 2020-2022
  • Figure 60: Sysmex Corporation: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Impact Analysis of Market Drivers, and Restraints on the Asia-Pacific Next-Generation IVD Market
  • Table 2: Impact of COVID-19 on Different Countries
  • Table 3: Asia-Pacific: Market Dynamics
  • Table 4: Next-Generation IVD Market, Active Players